Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - nevirapine - tablet - 200mg

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - rifabutin 150mg - capsule - 150 mg - active: rifabutin 150mg - mycobutin is indicated for infections caused by mycobacteria, such as m. tuberculosis, m. avium intracellulare complex (mac) and other atypical mycobacteria. in infections caused by mac and other atypical mycobacteria such as m. xenopi, mycobutin has been shown to be effective for the treatment of both disseminated and localised disease, also in immunocompromised hiv positive patients. mycobutin is also indicated for the prophylaxis of m. avium intracellulare complex (mac) infections in immunodepressed patients with cd4 counts lower than or equal to 100/ml. in the treatment of tubercular disease, mycobutin has been shown to be effective for the treatment of patients with chronic pulmonary tuberculosis, even if caused by multidrug-resistant m. tuberculosis strains. in accordance with the commonly accepted criteria for the treatment of mycobacterial infections, mycobutin therapy should always be given in combination with other antimycobacterial drugs not belonging to the family of rifamycins.

Singapor - Ingliż - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - darunavir ethanolate 867.28mg eqv darunavir - tablet, film coated - 800 mg - darunavir ethanolate 867.28mg eqv darunavir 800 mg

Singapor - Ingliż - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - darunavir ethanolate 162.62 mg eqv darunavir - tablet, film coated - 150mg - darunavir ethanolate 162.62 mg eqv darunavir 150mg

Singapor - Ingliż - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - darunavir ethanolate 433.64 mg eqv darunavir - tablet, film coated - 400mg - darunavir ethanolate 433.64 mg eqv darunavir 400mg

Singapor - Ingliż - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - darunavir ethanolate 650.46 mg eqv darunavir; darunavir ethanolate eqv darunavir - tablet, film coated - 600mg - darunavir ethanolate 650.46 mg eqv darunavir 600mg; darunavir ethanolate eqv darunavir 600mg

Singapor - Ingliż - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - darunavir ethanolate 81.31 mg eqv darunavir - tablet, film coated - 75mg - darunavir ethanolate 81.31 mg eqv darunavir 75mg

Iżrael - Ingliż - Ministry of Health

boehringer ingelheim israel ltd. - nevirapine anhydrous (as hemihydrate) - suspension - nevirapine anhydrous (as hemihydrate) 50 mg / 5 ml - nevirapine - nevirapine - for use in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - nevirapine anhydrous - prolonged-release tablet - 400 milligram(s) - non-nucleoside reverse transcriptase inhibitors; nevirapine

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - nevirapine hemihydrate - oral suspension - 10mg/1ml